Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Weijin Huang and Youchun Wang.
Connection Strength

5.599
  1. Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants. Emerg Microbes Infect. 2021 Dec; 10(1):1519-1529.
    View in: PubMed
    Score: 0.245
  2. Three epitope-distinct human antibodies from RenMab mice neutralize SARS-CoV-2 and cooperatively minimize the escape of mutants. Cell Discov. 2021 Jul 20; 7(1):53.
    View in: PubMed
    Score: 0.239
  3. The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom. Front Immunol. 2021; 12:687869.
    View in: PubMed
    Score: 0.238
  4. Cellular tropism and antigenicity of mink-derived SARS-CoV-2 variants. Signal Transduct Target Ther. 2021 05 17; 6(1):196.
    View in: PubMed
    Score: 0.236
  5. Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses. Cell Discov. 2021 Apr 06; 7(1):21.
    View in: PubMed
    Score: 0.235
  6. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell. 2021 04 29; 184(9):2362-2371.e9.
    View in: PubMed
    Score: 0.233
  7. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg Microbes Infect. 2020 Dec; 9(1):680-686.
    View in: PubMed
    Score: 0.229
  8. Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. Nat Protoc. 2020 11; 15(11):3699-3715.
    View in: PubMed
    Score: 0.226
  9. The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity. Cell. 2020 09 03; 182(5):1284-1294.e9.
    View in: PubMed
    Score: 0.223
  10. A Mouse Model of SARS-CoV-2 Infection and Pathogenesis. Cell Host Microbe. 2020 07 08; 28(1):124-133.e4.
    View in: PubMed
    Score: 0.221
  11. Detection of Hepatitis E Virus in Raw Pork and Pig Viscera As Food in Hebei Province of China. Foodborne Pathog Dis. 2019 05; 16(5):325-330.
    View in: PubMed
    Score: 0.203
  12. Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities. Emerg Microbes Infect. 2019; 8(1):272-281.
    View in: PubMed
    Score: 0.201
  13. Antigenic Drift of Influenza A(H7N9) Virus Hemagglutinin. J Infect Dis. 2019 01 01; 219(1):19-25.
    View in: PubMed
    Score: 0.201
  14. Hepatitis E virus was not detected in feces and milk of cows in Hebei province of China: No evidence for HEV prevalence in cows. Int J Food Microbiol. 2019 Feb 16; 291:5-9.
    View in: PubMed
    Score: 0.198
  15. A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV. Viruses. 2018 08 23; 10(9).
    View in: PubMed
    Score: 0.196
  16. Current status on the development of pseudoviruses for enveloped viruses. Rev Med Virol. 2018 01; 28(1).
    View in: PubMed
    Score: 0.186
  17. Development and optimization of a sensitive pseudovirus-based assay for HIV-1 neutralizing antibodies detection using A3R5 cells. Hum Vaccin Immunother. 2018 01 02; 14(1):199-208.
    View in: PubMed
    Score: 0.184
  18. Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization. J Infect Dis. 2017 10 17; 216(7):867-876.
    View in: PubMed
    Score: 0.184
  19. Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system. Vaccine. 2017 11 07; 35(47):6387-6394.
    View in: PubMed
    Score: 0.184
  20. An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions. Vaccine. 2017 09 12; 35(38):5172-5178.
    View in: PubMed
    Score: 0.182
  21. Biodistribution and residence time of adenovector serotype 5 in normal and immunodeficient mice and rats detected with bioluminescent imaging. Sci Rep. 2017 06 15; 7(1):3597.
    View in: PubMed
    Score: 0.180
  22. A bioluminescent imaging mouse model for Marburg virus based on a pseudovirus system. Hum Vaccin Immunother. 2017 08 03; 13(8):1811-1817.
    View in: PubMed
    Score: 0.179
  23. Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection. Sci Rep. 2017 03 30; 7:45552.
    View in: PubMed
    Score: 0.178
  24. Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19. Emerg Microbes Infect. 2021 Dec; 10(1):1574-1588.
    View in: PubMed
    Score: 0.061
  25. Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants. Cell Res. 2021 10; 31(10):1130-1133.
    View in: PubMed
    Score: 0.060
  26. A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants. Nat Commun. 2021 08 17; 12(1):5000.
    View in: PubMed
    Score: 0.060
  27. Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage. Bioorg Chem. 2021 10; 115:105196.
    View in: PubMed
    Score: 0.060
  28. Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2. Nat Commun. 2021 07 09; 12(1):4210.
    View in: PubMed
    Score: 0.060
  29. Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines. Cell Res. 2021 07; 31(7):732-741.
    View in: PubMed
    Score: 0.059
  30. The first Chinese national standards for SARS-CoV-2 neutralizing antibody. Vaccine. 2021 06 23; 39(28):3724-3730.
    View in: PubMed
    Score: 0.059
  31. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development. Signal Transduct Target Ther. 2021 03 27; 6(1):134.
    View in: PubMed
    Score: 0.059
  32. Publisher Correction: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2021 Feb; 590(7844):E23.
    View in: PubMed
    Score: 0.058
  33. Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals. Nat Microbiol. 2021 01; 6(1):51-58.
    View in: PubMed
    Score: 0.057
  34. Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy. Cell. 2020 11 12; 183(4):1013-1023.e13.
    View in: PubMed
    Score: 0.056
  35. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2020 10; 586(7830):572-577.
    View in: PubMed
    Score: 0.056
  36. Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody. Science. 2020 09 18; 369(6510):1505-1509.
    View in: PubMed
    Score: 0.056
  37. A Thermostable mRNA Vaccine against COVID-19. Cell. 2020 09 03; 182(5):1271-1283.e16.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.